Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1CNS 1

Conditions

Venous Thromboembolism 16Neoplasms 9Treatment of Venous Thromboembolism in Cancer Patients 3Thrombosis 2Pulmonary Embolism 2Multiple Myeloma 2Venous Thrombosis 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urogenital Neoplasms 1Prevention of Venous Thromboembolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Ovarian Neoplasms 1Lymphoma 1Lung Neoplasms 1Leukemia 1Hematologic Neoplasms 1Glioma 1Endometrial Neoplasms 1Embolism 1Dyskinesias 1Carcinoma, Non-Small-Cell Lung 1

Interventions

apixaban 1Temozolomide 1Rivaroxaban 1Radiotherapy 1Long-Term Synaptic Depression 1Dalteparin 1Comparative Genomic Hybridization 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × Rivaroxaban × Classical hematology × Clear all
NCT06196918 2024-01-09

Efficacy and Safety of Rivaroxaban in the Prevention of Venous Thromboembolism in Glioma Patients

Nanfang Hospital, Southern Medical University

Phase NA Unknown
320 enrolled
CNSClassical hematology

Glioma, Dyskinesias, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡